Title: Anti-TNF therapy for Ulcerative Colitis in Brazil: a comparative real-world national
retrospective multicentric study from the Brazilian Study Group of IBD (GEDIIB)
Version: 2 Date: 12 Mar 2022
Reviewer's report:
The authors reported the results of the use of anti-TNF agents in Brazilian patients with ulcerative
colitis. This is a valuable and interesting paper, as there has been no report of its use in Brazil
until now.
Some modifications are necessary in order to publish this paper.
1) It is stated that the use of biologics precedes the use of anti-TNF agents, how long ago was
this used and what is the formulation used?
2) Infliximab and adalimumab are sometimes switched and both formulations are used, is this
discussed in this study?
Title: Anti-TNF therapy for Ulcerative Colitis in Brazil: a comparative real-world national
retrospective multicentric study from the Brazilian Study Group of IBD (GEDIIB)
Version: 2 Date: 12 Mar 2022
Reviewer's report:
The authors reported the results of the use of anti-TNF agents in Brazilian patients with ulcerative
colitis. This is a valuable and interesting paper, as there has been no report of its use in Brazil
until now.
Some modifications are necessary in order to publish this paper.
1) It is stated that the use of biologics precedes the use of anti-TNF agents, how long ago was
this used and what is the formulation used?
2) Infliximab and adalimumab are sometimes switched and both formulations are used, is this
discussed in this study?
Please review this paper.
user
Title: Anti-TNF therapy for Ulcerative Colitis in Brazil: a comparative real-world national
retrospective multicentric study from the Brazilian Study Group of IBD (GEDIIB)
Version: 2 Date: 12 Mar 2022
Reviewer's report:
The authors reported the results of the use of anti-TNF agents in Brazilian patients with ulcerative
colitis. This is a valuable and interesting paper, as there has been no report of its use in Brazil
until now.
Some modifications are necessary in order to publish this paper.
1) It is stated that the use of biologics precedes the use of anti-TNF agents, how long ago was
this used and what is the formulation used?
2) Infliximab and adalimumab are sometimes switched and both formulations are used, is this
discussed in this study?
assistant